Synlogic, Inc.
General ticker "SYBX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.2M (TTM average)
Synlogic, Inc. follows the US Stock Market performance with the rate: 3.0%.
Estimated limits based on current volatility of 2.5%: low 1.03$, high 1.08$
Factors to consider:
- Total employees count: 1 (0.0%) as of 2025
- Top business risk factors: Strategic risks and growth management, SYNB1934 development discontinuation, Liquidation risk, Intellectual property risks, Operational and conduct risks
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.78$, 2.15$]
- 2026-12-31 to 2027-12-31 estimated range: [0.66$, 1.86$]
Financial Metrics affecting the SYBX estimates:
- Positive: with PPE of -13.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: Industry earnings per price (median), % of -15.99 <= 0
- Negative: Investing cash flow per share per price, % of 1.16 <= 2.08
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: 69.38 < Shareholder equity ratio, % of 76.80 <= 81.92
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -6.11
Short-term SYBX quotes
Long-term SYBX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.37MM | $0.01MM | $0.00MM |
| Operating Expenses | $58.53MM | $40.96MM | $4.01MM |
| Operating Income | $-55.16MM | $-40.95MM | $-4.01MM |
| Non-Operating Income | $-2.11MM | $17.60MM | $3.00MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $43.97MM | $9.15MM | $0.04MM |
| Income(Loss) | $-57.27MM | $-23.35MM | $-1.00MM |
| Taxes | $0.01MM | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-57.28MM | $-23.36MM | $-1.00MM |
| Stockholders Equity | $42.66MM | $12.75MM | $11.86MM |
| Assets | $75.55MM | $19.83MM | $15.45MM |
| Operating Cash Flow | $-51.61MM | $-31.66MM | $-4.36MM |
| Capital expenditure | $0.21MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $38.77MM | $25.34MM | $0.17MM |
| Financing Cash Flow | $20.94MM | $0.17MM | $0.00MM |
| Earnings Per Share** | $-8.81 | $-1.92 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.